Literature DB >> 22055202

Blocking TREM-1 signaling prolongs survival of mice with Pseudomonas aeruginosa induced sepsis.

Feng Wang1, Shuanglin Liu, Shiji Wu, Qin Zhu, Guoping Ou, Cailin Liu, Yue Wang, Yalong Liao, Ziyong Sun.   

Abstract

TREM-1 is a recently discovered receptor expressed on neutrophils and macrophages. Blocking of TREM-1 signaling improves the survival of mice with bacterial sepsis. However, the precise mechanism by which TREM-1 modulates the inflammatory responses is poorly defined. In this study, we investigated the role of TREM-1 in Pseudomonas aeruginosa-induced peritonitis. Our results showed that TREM-1 was not expressed on lymphocytes but emerged on the cell surface of neutrophils and peritoneal macrophages. Blockade of TREM-1 signaling significantly prolonged survival of mice with P. aeruginosa-induced peritonitis. However, blocking TREM-1 signaling had no effect on macrophage phagocytosis in vitro. Interestingly, the expression of the costimulatory molecules CD40 and CD86 on macrophages was significantly decreased after blocking TREM-1 signaling. Furthermore, interfering with TREM-1 engagement led to significant reduction of pro-inflammatory mediators such as IL-1, TNF-α, MCP-1 and IFN-γ. Therefore, our results showed that TREM-1 could be a potential therapeutic target for bacterial sepsis.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22055202     DOI: 10.1016/j.cellimm.2011.10.006

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  28 in total

1.  TREM-1 promotes survival during Klebsiella pneumoniae liver abscess in mice.

Authors:  Yi-Tsung Lin; Kai-Yu Tseng; Yi-Chen Yeh; Fu-Chen Yang; Chang-Phone Fung; Nien-Jung Chen
Journal:  Infect Immun       Date:  2014-01-06       Impact factor: 3.441

2.  TREM-1 signaling promotes host defense during the early stage of infection with highly pathogenic Streptococcus suis.

Authors:  Chao Yang; Bo Chen; Jianqing Zhao; Lan Lin; Li Han; Shan Pan; Lei Fu; Meilin Jin; Huanchun Chen; Anding Zhang
Journal:  Infect Immun       Date:  2015-06-08       Impact factor: 3.441

Review 3.  Single versus combined immunoregulatory approach using PD-1 and CTLA-4 modulators in controlling sepsis.

Authors:  Courtney P Rudick; David L Cornell; Devendra K Agrawal
Journal:  Expert Rev Clin Immunol       Date:  2017-07-28       Impact factor: 4.473

4.  TREM-1 modulation produces positive outcome on the histopathology and cytokines release profile of Plasmodium berghei-infected mice.

Authors:  Voon Kin Chin; Afiq Mohd Yusof Asyran; Zainul Amiruddin Zakaria; Wan Omar Abdullah; Pei Pei Chong; Norshariza Nordin; Zaid Osamah Ibraheem; Roslaini Abdul Majid; Rusliza Basir
Journal:  J Parasit Dis       Date:  2018-12-15

Review 5.  TREM-1 Modulation Strategies for Sepsis.

Authors:  Sara Siskind; Max Brenner; Ping Wang
Journal:  Front Immunol       Date:  2022-06-15       Impact factor: 8.786

6.  A novel ligand-independent peptide inhibitor of TREM-1 suppresses tumor growth in human lung cancer xenografts and prolongs survival of mice with lipopolysaccharide-induced septic shock.

Authors:  Alexander B Sigalov
Journal:  Int Immunopharmacol       Date:  2014-05-14       Impact factor: 4.932

Review 7.  Current trends in inflammatory and immunomodulatory mediators in sepsis.

Authors:  Monowar Aziz; Asha Jacob; Weng-Lang Yang; Akihisa Matsuda; Ping Wang
Journal:  J Leukoc Biol       Date:  2012-11-07       Impact factor: 4.962

8.  Triggering receptor expressed on myeloid cells-1 (Trem-1) on blood neutrophils is associated with cytokine inducibility in human E. coli sepsis.

Authors:  Tobias van Bremen; Daniel Drömann; Karin Luitjens; Christoph Dodt; Klaus Dalhoff; Torsten Goldmann; Bernhard Schaaf
Journal:  Diagn Pathol       Date:  2013-02-15       Impact factor: 2.644

9.  Reversal of TREM-1 ectodomain shedding and improved bacterial clearance by intranasal metalloproteinase inhibitors.

Authors:  G Weiss; C Lai; M E Fife; A M Grabiec; B Tildy; R J Snelgrove; G Xin; C M Lloyd; T Hussell
Journal:  Mucosal Immunol       Date:  2016-12-14       Impact factor: 7.313

10.  Increased sTREM-1 plasma concentrations are associated with poor clinical outcomes in patients with COVID-19.

Authors:  Aline H de Nooijer; Inge Grondman; Simon Lambden; Emma J Kooistra; Nico A F Janssen; Matthijs Kox; Peter Pickkers; Leo A B Joosten; Frank L van de Veerdonk; Marc Derive; Sebastien Gibot; Mihai G Netea
Journal:  Biosci Rep       Date:  2021-07-30       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.